!-- Nivo Slider Theme -->
×
Make a Difference with Frost & Sullivan's Growth Pipeline Dialog™ Frost Radar—Non-Invasive Prenatal Testing, 2021 Key Innovations Influencing the Growth of Small Molecule Contract Development and Manufacturing Organizations Transformative Business Strategies Present New Growth Prospects for Medical Device Leasing VC Investment in the US and EU Biotech Industry Paves Way for Massive Growth Opportunities Latest Advancements Drive the Growth of Decentralized Clinical Trials

Growth Opportunities

Renal Care Management: Smart Approaches Accelerate Growth
Renal Care Management: Smart Approaches Accelerate Growth

Explore the need to shift from a reactive treatment-based approach to proactive, value-based renal care management. Also, identify innovative solutions with high potential, short- and long-term growth opportunities for medical devices, and technology participants.

Read more Request Info
Key Growth Opportunities for US & EU Upstream Bioprocessing
Key Growth Opportunities for US & EU Upstream Bioprocessing

Take an in-depth look at the biologics drug development pipeline and capacity expansion plans of biologics contract development and manufacturing organizations (CDMOs) and biopharmaceutical companies. Gain strategic insights on the bioprocessing industry.

Read more Request Info
New-age Technologies Boost the Growth of Wound Care Solutions
New-age Technologies Boost the Growth of Wound Care Solutions

This research analyzes the major segments of this sector, including basic, surgical, and advanced wound care solutions. It also examines the impact of new-age, AI-based solutions such as 3D-bioprinted scaffolds, sensor-embedded early detection scanners, autologous wound patches, etc.

Read more Request Info

CxO Insights

Growth-diagnostic-image

Three Reasons Why Sustainable Energy is Getting a Boost Despite Low Oil Prices

Vivek Vaidya
Associate Partner & SVP – Mobility Practice, APAC

Due to the global pandemic, we are living in unprecedented times. This pandemic has proven to be the ultimate iconoclasm across industries. Everything is on the anvil, from business attire to face-to-face meetings to the need to have a permanent office. Sustainable energy is no different. When the pandemic set in and oil prices plummeted, the most common belief was that the investments in sustainable energy will slow down, the new wave of electrification in automotive will subside and we will turn the clock back on the climate agenda.

Prolonged lockdowns in several countries turned out to be an unprecedented social experiment. When the transport and industrial emissions stopped, urban air quality drastically improved in a matter of days. That underlined the harmful effects of the emissions.

1. Sales of electric vehicles (EV) continue unabated. In countries like Germany, EV penetration has exploded.

2. As per the International Energy Agency (IEA), electricity generation by renewable sources grew against the decline in other conventional energy sources.

3. Investments in renewable energy and new zero-carbon fuels like hydrogen increased multi-fold.

Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.

Top Growth Insights

Growth Potential of Drug Discovery and Early Development Outsourcing
Drug Discovery

Growth Potential of Drug Discovery and Early Development Outsourcing

Read more Request Info
US Healthcare Consumerism: Growth-based Business Models Revealed
Healthcare Consumerism

US Healthcare Consumerism: Growth-based Business Models Revealed

Read more Request Info
Potential Growth Opportunities for Computed Tomography
Computed Tomography

Potential Growth Opportunities for Computed Tomography

Read more Request Info
Medical Imaging & Informatics: Future Growth Potential Unveiled
Imaging & Informatics

Medical Imaging & Informatics: Future Growth Potential Unveiled

Read more Request Info
Potential Growth Opportunities in the Global Biologics Contract Development and Manufacturing Landscape
Biologics

Potential Growth Opportunities in the Global Biologics Contract Development and Manufacturing Landscape

Read more Request Info
Novel Growth Avenues and Transformational Hubs for MedTech in the US Healthcare Provider Ecosystem
MedTech

Transformational Hubs for MedTech in the US Healthcare Provider Ecosystem

Read more Request Info
The Explosion of Data Accelerates the Growth of the US Social Determinants of Health Sector
Social Determinants of Health

The Explosion of Data Accelerates the Growth of the US Social Determinants of Health Sector

Read more Request Info
IoT-Based Technologies and Patient Preference Propel Growth Prospects for Global Home Healthcare Solutions
Home Healthcare

IoT-Based Technologies and Patient Preference Propel Growth Prospects for Global Home Healthcare Solutions

Read more Request Info

Analyst Insights

Frost & Sullivan's latest white paper, Improving Patient Care with the Smith+Nephew LEAF Patient Monitoring System, discusses the significant problem of hospital-acquired pressure injuries, the operational and economic impacts of HAPIs on providers, and the potential benefits that a patient-worn sensor solution can bring to managing the condition more effectively.
Read more

The shift to value-based care relies heavily on evidence-based medicine, and pharmaceutical companies play an important role in scientific communication across the healthcare ecosystem. Medical affairs experts interact with healthcare professionals to understand patients’ needs, interpret scientific data regarding therapeutic options, and then engage providers with hyper-relevant communication to help them make informed decisions.
Read more

SPAC (Special Purpose Acquisition Company) is emerging as a popular route that enables companies to join public stock markets without going through the IPO process, with digital health certainly riding this wave. The first two months of 2021 saw 144 SPACs, raising $44 billion, with ten digital health deals in the first quarter of 2021, including Revolution Healthcare, Blueprint Health Merger.
Read more

Press Releases

Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe

Frost & Sullivan’s recent analysis, 'Global RNA Therapeutics: Technology Growth Opportunities', reveals that ribonucleic acid (RNA) therapeutics is poised to gain momentum in the next few years and can potentially be applied to a wide variety of disease interventions. Additionally, the growth opportunities exposed by the initial commercialization of mRNA vaccines, antisense oligonucleotides (ASOs) and short interfering RNA (siRNA)-based therapeutics are further attracting pharmaceutical and biotechnology companies to invest in this space and expedite research and development (R&D).

Read more

Frost & Sullivan Unfolds Top 5 Transformational Shifts Redefining the Healthcare Supply Chain

The dynamics of the COVID-19 pandemic, including multi-country shutdowns, put an excessive amount of pressure on healthcare supply chains worldwide. There are clear signs that the pandemic will be here in the long run, driving healthcare companies to address supply chain vulnerabilities. Pharmaceutical companies relied heavily on an unprecedented level of cooperation from raw material suppliers, government agencies, and contract development and manufacturing organizations.

Read more

Data Mining will Become Essential to Reduce the Disease Burden and Empower Healthcare Stakeholders

With the rising number of stakeholders playing a role in medical decision-making, pharmaceutical companies are looking for more effective ways to communicate the value of an innovative treatment. They are increasingly turning to actionable, evidence-based programs to convince these stakeholders of the value of the treatment. A comprehensive data set can help an analytics team map a treatment journey and quickly identify the patients and physicians who are most likely to benefit from a novel therapy.

Read more

What's New?

Growth Opportunity Briefings
  • Follow us  

Subscribe to the Healthcare & Lifesciences Newsletter

Subscribe

Featured

Upcoming Events You Won't Want to Miss

Customer contact mindexchange
Customer contact Europe
Customer contact Europe
Product Innovation development
STAR Sep event
STAR Sep event

Frost & Sullivan Institute

Frost & Sullivan Institute

Click here to read more

Advertisement Queries

AD_banner

Click Here For More Info